On April 27, MedSci Healthcare Holdings Limited (stock code: "02415.HK") was successfully listed on the main board of the Hong Kong Stock Exchange with an issue price of HK $9.10 per share and an issue size of HK $608 million.
MedSci Healthcare is a comprehensive Internet platform for doctors. It applies big data and artificial intelligence technology to connect doctors, patients and pharmaceutical equipment enterprises, providing precise digital medical communication solutions, empowering medical ecology and improving medical quality. Its main products include platform solutions, digital medical communication solutions, digital clinical research solutions, covering clinical research, doctor career growth, multi-channel academic communication and other categories.
The listing intermediary team includes:
CICC and Macquarie Capital as co-sponsors;
Davis Polk & Wardwell is the company's legal counsel in Hong Kong and the United States, and Commerce & Finance Law Offices is the company's legal counsel in China.
Herbert Smith Freehills is the Hong Kong and US legal counsel for the underwriters, and Jingtian & Gongcheng is the China legal counsel for the underwriters.
Ernst & Young as auditor;
Frost & Sullivan is an industry consultant.